Poszttranszplantációs hypertonia rizikófaktora és hatása az allograft funkciójára

Introduction: Cardiovascular diseases are the leading causes of death after kidney transplantation, one of the major risk factors of which is post transplant hypertension (PTHT), which is often unrecognized and therefore untreated. Material and methods: In this study, the incidence and risk factors...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Harsányi Márton
Rárosi Ferenc
Borda Bernadett
Dokumentumtípus: Cikk
Megjelent: 2023
Sorozat:HYPERTONIA ÉS NEPHROLOGIA 27 No. 1
Tárgyszavak:
doi:10.33668/hn.27.001

mtmt:33692526
Online Access:http://publicatio.bibl.u-szeged.hu/27050
LEADER 01897nab a2200241 i 4500
001 publ27050
005 20230426085646.0
008 230426s2023 hu o 0|| Magyar d
022 |a 1418-477X 
024 7 |a 10.33668/hn.27.001  |2 doi 
024 7 |a 33692526  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a Magyar 
100 1 |a Harsányi Márton 
245 1 0 |a Poszttranszplantációs hypertonia rizikófaktora és hatása az allograft funkciójára  |h [elektronikus dokumentum] /  |c  Harsányi Márton 
260 |c 2023 
300 |a 4-6 
490 0 |a HYPERTONIA ÉS NEPHROLOGIA  |v 27 No. 1 
520 3 |a Introduction: Cardiovascular diseases are the leading causes of death after kidney transplantation, one of the major risk factors of which is post transplant hypertension (PTHT), which is often unrecognized and therefore untreated. Material and methods: In this study, the incidence and risk factors of PTHT were examined. The effect of blood pressure on graft function. Results: The incidence of PTHT was 42%. Regarding the risk factors, no significant difference was revealed. PTHT was significantly higher in cyclosporine users (p=0.021), than in tacrolimus users. Significant differences were found in case of renal function: serum creatinine (p=0.024), urea (p=0.005), and eGFR (p=0.036) in patients with PTHT. Discussion: The harmful effect of newly developed hypertension after transplantation on the graft was seen after transplantation in renal function. Therefore, we consider it essential to monitor blood pressure regularly and to start antihypertensive therapy if necessary. 
650 4 |a Klinikai orvostan 
700 0 1 |a Rárosi Ferenc  |e aut 
700 0 1 |a Borda Bernadett  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/27050/1/HarsanyiMartonRarosiFerencBordaBernadettPoszttranszplantacioshypertoniarizikofaktoraeshatasaazallograftfunkciojara.pdf  |z Dokumentum-elérés